Course Description
Measurement-based care is an important component of evidence-based psychiatric practice, yet some clinicians lack practical experience translating assessment scores into actionable treatment decisions. In this highly interactive workshop, learners will work in small groups with dedicated facilitators to interpret Patient Health Questionnaire-9 (PHQ-9) and General Anxiety Disorder-7 (GAD-7) scores, apply findings to patient cases, and make informed treatment and follow-up decisions. Through hands-on case activities, discussion, and real-time facilitator feedback, participants will build skills for translating assessment results into meaningful clinical action and evaluating changes over time. The small group format will provide opportunities to explore practical considerations and clinical pearls related to interpreting and applying these tools in practice. Space is limited to 36 learners to support an engaging, collaborative learning experience.
This session will only be offered live for in-person attendees. The session will not be recorded and will not be available for home study.
Learning Objectives
- Interpret scores from the Patient Health Questionnaire-9 (PHQ-9) and the General Anxiety Disorder-7 (GAD-7) tools using established scoring criteria and clinical thresholds.
- Integrate PHQ-9 and GAD-7 scores with patient-specific information to guide treatment decisions and follow-up.
- Evaluate changes in PHQ-9 and GAD-7 scores over time in relation to treatment response.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Dana Chiulli, PharmD, BCPP (Chair)
Mental Health Clinical Pharmacist Practitioner, Veterans Health Administration
VISN 6 Clinical Resource Hub
Dr. Dana Chiulli is a Mental Health Clinical Pharmacist Practitioner who has been working for the VHA since 2014; currently for the VISN 6 Clinical Resource Hub. She completed her PGY1 pharmacy practice residency at Baptist Medical Center in Jacksonville, Florida and her PGY2 2 psychiatric pharmacy residency at the San Diego VA Medical Center. Dr. Chiulli is board certified in Psychiatric Pharmacotherapy and has practiced in outpatient Mental Health and Primary Care Mental Health Integration. Dr. Chiulli Co-Chairs the VHA Clinical Pharmacy Program Office Mental Health Pharmacist Subject Matter Expert Workgroup. She has also served on the AAPP Program Committee, Summit Committee and Residency Program Director Community.
Richard J. Silvia, PharmD, MA, BCPP, FCCP, FAAPP
Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences
Boston, MA
Dr. Silvia earned his Doctor of Pharmacy degree from the University of Rhode Island and completed a two-year residency/fellowship in psychiatric pharmacy through the Institute of Living in Hartford, CT and the University of Connecticut. He joined the faculty of MCPHS in 2001, and is currently a Professor of Pharmacy Practice. He practices at the Codman Square Health Center in Dorchester, MA, maintaining a busy collaborative practice in integrated behavioral health within the center’s primary care clinics. His clinical practice provides needed medications for approximately 100 patients with a variety of mental illnesses. While he has been engaged in collaborative practice for nearly 10 years, he also has previous clinical experience in both private and state psychiatric hospitals as well as within the Boston VA Healthcare System. He is a Board Certified in Psychiatric Pharmacist (BCPP), and is active in the American Association of Psychiatric Pharmacists (AAPP), American Association of Colleges of Pharmacy (AACP), and American College of Clinical Pharmacy (ACCP), of which he is a Fellow (FCCP). He has served as the chair of the Professional Affairs Committee of AAPP from 2020-22, advocating for the expansion of psychiatric pharmacist services with other healthcare providers, and led an AAPP task force to develop a best practice model for outpatient psychiatric pharmacists, a multi-year project. He has also consulted with other clinical pharmacists starting their own collaborative practice agreements to assist their efforts. He also recently completed a Masters of Arts in Adult Education through the University of Rhode Island in December, 2023. His research interests include measuring the effectiveness of clinical pharmacists in novel practice settings and studying the adverse effects observed with psychotropic medications and the appropriate management and treatment of these adverse effects. In his spare time, he enjoys spending time with his wife and daughter and their pets, playing music and softball, and woodworking.
Caitlin McCoyd, PharmD, BCPP
Clinical Associate Professor, Rutgers University Ernest Mario School of Pharmacy
Piscataway, NJ
Dr. Caitlin McCoyd is a Clinical Associate Professor in the Department of Pharmacy Practice and Administration at the Ernest Mario School of Pharmacy (EMSOP), Rutgers, the State University of New Jersey. Dr. McCoyd mcarthyis a Board Certified Psychiatric Pharmacist who provides clinical pharmacy services at Henry J. Austin Health Center (HJAHC), a Federally Qualified Health Center located in Trenton, NJ that follows an integrated behavioral health care model to provide outpatient care to underserved patients. At HJAHC, pharmacists are encouraged to practice at the top of their licensing and training and have prescriptive authority.
Dr. McCoyd received her Doctor of Pharmacy from Rutgers University where she completed a specialty residency in neuropsychopharmacology. At EMSOP, Dr. McCoyd is a Co-Chair of the Experiential Education Committee, is a member of the Interprofessional Education Committee and the PharmD/MD Committee, and is a Rutgers University Senator. At HJAHC, Dr. McCoyd is a member of several committees and acts as the Secretary for the Institutional Review Board. Dr. McCoyd’s teaching and research interests include health care delivery, integrated behavioral health, chronic disease management, depressive disorders, and anxiety disorders. Dr. McCoyd is dedicated to the optimization of patient care through innovative care models and education of patients and practitioners alike regarding the relationship between mental and physical health.
Lacey J. Vann, PharmD, BCPP
Mental Health Clinical Pharmacist Practitioner, Ralph H. Johnson Veterans Affairs Medical Center
Savannah, GA
Dr. Vann is a Mental Health Clinical Pharmacist Practitioner who has served the Department of Veterans Affairs since 2012. She earned a bachelor’s degree in Biology from the University of Georgia and a Doctor of Pharmacy degree from South University. She completed a PGY1 Pharmacy Practice Residency at the Northern California VA Medical Center, followed by a PGY2 Psychiatric Pharmacy Residency at the Palo Alto VA Medical Center.
Board certified in Psychiatric Pharmacotherapy, Dr. Vann specializes in outpatient mental health and Primary Care Mental Health Integration. She serves as a Mental Health Subject Matter Expert for the Clinical Pharmacy Practice Office, champions the Psychotropic Drug Safety Initiative for her facility, and leads the VISN 7 Psychopharmacology Committee. Through her practice and leadership, Dr. Vann promotes collaborative, patient-centered care that incorporates measurement-based care, empowers Veterans to actively participate in treatment, and supports safe and effective medication management.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 4/6/2027-4/6/2030
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-##-###-###-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
View AAPP's Disclaimer and Disclosure Declarations
AAPP Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Unlabeled Use Disclosure: Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. The faculty, planners, and American Association of Psychiatric Pharmacists do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
View AAPP's Copyright Statement, Terms of Use, and Policies
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View AAPP's Privacy Policy. AAPP's Terms of Use and other policies on education programs, resources, toolkits, and other web based content/offerings are available here.
View AAPP's Fair Balance and Integrity Statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.